GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gubra AS (CHIX:GUBRAc) » Definitions » ROE % Adjusted to Book Value

Gubra AS (CHIX:GUBRAC) ROE % Adjusted to Book Value : -0.95% (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Gubra AS ROE % Adjusted to Book Value?

Gubra AS's ROE % for the quarter that ended in Jun. 2024 was -8.54%. Gubra AS's PB Ratio for the quarter that ended in Jun. 2024 was 9.00. Gubra AS's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was -0.95%.

Gubra AS ROE % Adjusted to Book Value Historical Data

The historical data trend for Gubra AS's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gubra AS ROE % Adjusted to Book Value Chart

Gubra AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
- - - - -

Gubra AS Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
ROE % Adjusted to Book Value Get a 7-Day Free Trial - - - - -0.95

Competitive Comparison of Gubra AS's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Gubra AS's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gubra AS's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gubra AS's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Gubra AS's ROE % Adjusted to Book Value falls into.


Gubra AS ROE % Adjusted to Book Value Calculation

Gubra AS's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-15.15% / N/A
=N/A

Gubra AS's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-8.54% / 9.00
=-0.95%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gubra AS ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Gubra AS's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Gubra AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gubra AS (CHIX:GUBRAc) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
OCSE:PEG A OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX SZSE:300122 BGNE ALNY OCSE:GMAB BMRN XKRX:068270 XBRU:UCB RPRX INCY
Traded in Other Exchanges
GUBRA:Denmark PI3:Germany
Address
Horsholm Kongevej 11B, Horsholm, DNK, 2970
Website
https://www.gubra.dk
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases. The company has three segments: Pre-clinical contract research (CRO), which derives maximum revenue; Discovery & Partnerships (D&P) Segment; and Gubra Green Segment.

Gubra AS Headlines

No Headlines